Immunoinformatic Design and Immunoprotective Effect of an mCTA1 ‐ and Smp145‐Based Vaccine Against Naegleria fowleri
Parasite Immunology · 2025
DOI: 10.1111/pim.70028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Parasite Immunology, 2025. Verfasst von Frida Carrillo-Morales und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio de Inmunobiología Molecular y Celular, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécni…. Hauptthemen laut MEDLINE: Naegleria fowleri, Protozoan Vaccines, Central Nervous System Protozoal Infections, Protozoan Proteins. Die Arbeit nennt 75 Literaturangaben.
Abstract (Originalsprache)
Naegleria fowleri is the etiological agent of primary amoebic meningoencephalitis (PAM), a lethal disease with a 97% mortality rate in humans. Currently, there is no vaccine that confers protection against N. fowleri . Recently, we reported that the synthetic membrane peptide (Smp145) was considered as a vaccine candidate, since it induced 60% protection in mice immunised and challenged with N. fowleri . The objective was to design in silico a vaccine based on the A1 domain of cholera toxin (CT), coupled to the Smp145 peptide of N. fowleri , and to evaluate its protective effect in a murine model of PAM. A bioinformatic design was performed with the Ser61Phe mutation in the active site of the A1 domain of CT (mCTA1), linked through a glycine linker to Smp145. Intraperitoneal immunisation with mCTA1‐Smp145, followed by challenge with a lethal dose of N. fowleri , resulted in 60% protection, confirming its protective capacity as the most relevant finding. Furthermore, increased levels of IgA and IgG were observed in sera and nasal washes, which recognised antigenic bands of mCTA1‐Smp145 and total extracts of N. fowleri . Overall, we propose mCTA1‐Smp145 as a potential vaccine against N. fowleri , highlighting that its protective effect constitutes the main support for this proposal.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio de Inmunobiología Molecular y Celular, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, México City, México.
- Laboratorio de Microbiología, Grupo CyMA, Unidad de Investigación Interdisciplinaria en Ciencias de la Salud y la Educación, Universidad Nacional Autónoma de México, UNAM FES Iztacala, Tlalnepantla, México.
- Laboratorio de Diseño y Desarrollo de Nuevos Fármacos e Innovación Biotécnológica (Laboratory for the Design and Development of New Drugs and Biotechnological Innovation), Escuela Superior de Medicina, Instituto Politéc…
ORCID-Profile: Frida Carrillo-Morales, Mara Gutiérrez-Sánchez, Saúl Rojas-Hernández
Zitieren
APA
Carrillo-Morales, F., Gutiérrez-Sánchez, M., Carrasco-Yépez, M. M., de la Luz Ortega-Juárez, M., Herrera-Ceja, R. A., Ramírez-Salinas, G. L., Correa-Basurto, J., & Rojas-Hernández, S. (2025). Immunoinformatic Design and Immunoprotective Effect of an mCTA1 ‐ and Smp145‐Based Vaccine Against Naegleria fowleri. Parasite Immunology. https://doi.org/10.1111/pim.70028
Vancouver
Carrillo-Morales F, Gutiérrez-Sánchez M, Carrasco-Yépez MM, de la Luz Ortega-Juárez M, Herrera-Ceja RA, Ramírez-Salinas GL, et al. Immunoinformatic Design and Immunoprotective Effect of an mCTA1 ‐ and Smp145‐Based Vaccine Against Naegleria fowleri. Parasite Immunology. 2025. doi:10.1111/pim.70028
BibTeX
@article{CarrilloMorales2025,
author = {Carrillo-Morales, Frida and Gutiérrez-Sánchez, Mara and Carrasco-Yépez, María Maricela and de la Luz Ortega-Juárez, Maria and Herrera-Ceja, Rubén Armando and Ramírez-Salinas, Gema Lizbeth and Correa-Basurto, José and Rojas-Hernández, Saúl},
title = {Immunoinformatic Design and Immunoprotective Effect of an mCTA1 ‐ and Smp145‐Based Vaccine Against Naegleria fowleri},
journal = {Parasite Immunology},
year = {2025},
doi = {10.1111/pim.70028}
}
EUVIMED